Phosphorylation of IGFBP-1 at discrete sites elicits variable effects on IGF-I receptor autophosphorylation

Endocrinology

Volumn 154, Issue 3, 2013, Pages 1130-1143

  Shehab, Majida Abu ^a   Iosef, Cristiana ^a   Wildgruber, Robert ^b   Sardana, Girish ^c   Gupta, Madhulika B ^a,d  

^a Children's Health Research Institute   (Germany)

^b Free Flow Electrophoresis Service GmbH   (Germany)

^c Ontario Cancer Biomarker Network   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; MUTANT PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; BINDING AFFINITY; CHINESE HAMSTER; CONTROLLED STUDY; GENETIC TRANSFECTION; IN VITRO STUDY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ELECTROPHORESIS; PROTEIN PHOSPHORYLATION; SITE DIRECTED MUTAGENESIS; WILD TYPE;

AMINO ACID SUBSTITUTION; ANIMALS; BALB 3T3 CELLS; BINDING SITES; CHO CELLS; CRICETINAE; CRICETULUS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; KINETICS; MICE; MUTAGENESIS, SITE-DIRECTED; PHOSPHORYLATION; RECEPTOR, IGF TYPE 1; RECOMBINANT PROTEINS;

EID: 84874596201     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1962     Document Type: Article

References (52)

1. Clemmons DR, BusbyWH,Arai T, et al. Role of insulin-like growth factor binding proteins in the control of IGF actions. Prog Growth Factor Res. 1995;6:357-366.
2. Clemmons DR. Role of insulin-like growth factor binding proteins in controlling IGF actions. Mol Cell Endocrinol. 1998;140:19-24.
3. Jones JI, Doerr ME, Clemmons DR. Cell migration: Interactions among integrins, IGFs and IGFBPs. Prog Growth Factor Res. 1995; 6:319-327.
4. Firth SM, Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev. 2002;23:824-854.
5. Rajaram S, Baylink DJ,MohanS. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions. Endocr Rev. 1997;18:801-831.
6. Finlay D, Patel S, Dickson LM, et al. Glycogen synthase kinase-3 regulates IGFBP-1 gene transcription through the thymine-rich insulin response element. BMC Mol Biol. 2004;5:15.
7. Tazuke SI, Mazure NM, Sugawara J, et al. Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: A possible model for IGFBP-1 expression in fetal hypoxia. Proc Natl Acad Sci USA. 1998;95:10188-10193.
8. Angervo M, Koistinen R, Suikkari AM, Seppala M. Insulin-like growth factor binding protein-1 inhibits the DNA amplification induced by insulin-like growth factor I inhumangranulosa-luteal cells. Hum Reprod. 1991;6:770-773.
9. BusbyWHJr, KlapperDG,Clemmons DR. Purification of a 31,000-dalton insulin-like growth factor binding protein from human amniotic fluid. Isolation of two forms with different biologic actions. J Biol Chem. 1988;263:14203-14210.
10. Yee D, Jackson JG, Kozelsky TW, Figueroa JA. Insulin-like growth factor binding protein 1 expression inhibits insulin-like growth factor I action in MCF-7 breast cancer cells. Cell Growth Differ. 1994; 5:73-77.
11. Zhang X, Yee D. Insulin-like growth factor binding protein-1 (IGFBP-1) inhibits breast cancer cell motility. Cancer Res. 2002;62: 4369-4375.
12. Yu J, Iwashita M, Kudo Y, Takeda Y. Phosphorylated insulin-like growth factor (IGF)-binding protein-1 (IGFBP-1) inhibits while non-phosphorylated IGFBP-1 stimulates IGF-I-induced amino acid uptake by cultured trophoblast cells. Growth Horm IGF Res. 1998; 8:65-70.
13. Siddals KW, Westwood M, Gibson JM, White A. IGF-binding protein-1 inhibits IGF effects on adipocyte function: Implications for insulin-like actions at the adipocyte. J Endocrinol. 2002;174:289-297.
14. Liu L, Brinkman A, Blat C, Harel L. IGFBP-1, an insulin like growth factor binding protein, is a cell growth inhibitor. Biochem Biophys Res Commun. 1991;174:673-679.
15. Gibson JM, WestwoodM,Lauszus FF, Klebe JG, Flyvbjerg A, White A. Phosphorylated insulin-like growth factor binding protein 1 is increased in pregnant diabetic subjects. Diabetes. 1999;48:321-326.
16. Koistinen R, Angervo M, Leinonen P, Hakala T, Seppala M. Phosphorylation of insulin-like growth factor-binding protein-1 increases in human amniotic fluid and decidua from early to late pregnancy. Clin Chim Acta. 1993;215:189-199.
17. Clemmons DR, Jones JI, Busby WH, Wright G. Role of insulin-like growth factor binding proteins in modifying IGF actions. Ann N Y Acad Sci. 1993;692:10-21.
18. Heald AH, Siddals KW, Fraser W, et al. Low circulating levels of insulin-like growth factor binding protein-1 (IGFBP-1) are closely associated with the presence of macrovascular disease and hypertension in type 2 diabetes. Diabetes. 2002;51:2629-2636.
19. Janssen JA, Stolk RP, Pols HA, Grobbee DE, de Jong FH, Lamberts SW. Serum free IGF-I, total IGF-I, IGFBP-1 and IGFBP-3 levels in an elderly population: Relation to age and sex steroid levels. Clin Endocrinol (Oxf). 1998;48:471-478.
20. Borai A, Livingstone C, Ghayour-MobarhanM,et al. Serum insulinlike growth factor binding protein-1 (IGFBP-1) phosphorylation status in subjects with and without ischaemic heart disease. Atherosclerosis. 2010;208:593-598.
21. Popovici RM, Lu M, Bhatia S, Faessen GH, Giaccia AJ, Giudice LC. Hypoxia regulates insulin-like growth factor-binding protein 1 in human fetal hepatocytes in primary culture: Suggestive molecular mechanisms for in utero fetal growth restriction caused by uteroplacental insufficiency. J Clin Endocrinol Metab. 2001;86:2653- 2659.
22. Abu Shehab M, Khosravi J, Han VK, Shilton BH, Gupta MB. Sitespecific IGFBP-1 hyper-phosphorylation in fetal growth restriction: Clinical and functional relevance. J Proteome Res. 2010;9:1873- 1881.
23. Seferovic MD, Ali R, Kamei H, et al. Hypoxia and leucine deprivation induce human insulin-like growth factor binding protein-1 hyperphosphorylation and increase its biological activity. Endocrinology. 2009;150:220-231.
24. Temporini C, Dolcini L, Abee A, et al. Development of an integrated chromatographic system for on-line digestion and characterization of phosphorylated proteins. J Chromatogr A. 2008;1183:65-75.
25. Dolcini L, Sala A, Campagnoli M, et al. Identification of the amniotic fluid insulin-like growth factor binding protein-1 phosphorylation sites and propensity to proteolysis of the isoforms. FEBS J. 2009;276:6033-6046.
26. Nissum M, Abu Shehab M, Sukop U, et al. Functional and complementary phosphorylation state attributes of human insulin-like growth factor-binding protein-1 (IGFBP-1) isoforms resolved by free flow electrophoresis. Mol Cell Proteomics. 2009;8:1424-1435.
27. Abu Shehab M, Inoue S, Han VK, Gupta MB. Site specific phosphorylation of insulin-like growth factor binding protein-1 (IGFBP-1) for evaluating clinical relevancy in fetal growth restriction. J Proteome Res. 2009;8:5325-5335.
28. Ankrapp DP, Jones JI, Clemmons DR. Characterization of insulinlike growth factor binding protein-1 kinases from human hepatoma cells. J Cell Biochem. 1996;60:387-399.
29. Jones JI, Busby WH Jr, Wright G, Smith CE, Kimack NM, Clemmons DR. Identification of the sites of phosphorylation in insulinlike growth factor binding protein-1. Regulation of its affinity by phosphorylation of serine 101. J Biol Chem. 1993;268:1125-1131.
30. Jones JI, BusbyWHJr, Wright G, Clemmons DR. Human IGFBP-1 is phosphorylated on 3 serine residues: Effects of site-directed mutagenesis of the major phosphoserine. Growth Regul. 1993;3:37-40.
31. Sala A, Capaldi S, Campagnoli M, et al. Structure and properties of the C-terminal domain of insulin-like growth factor-binding protein-1 isolated from human amniotic fluid. J Biol Chem. 2005;280: 29812-29819.
32. Jones JI, D'Ercole AJ, Camacho-Hubner C, Clemmons DR. Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: Effects on affinity for IGF-I. Proc Natl Acad Sci U S A. 1991;88:7481-7485.
33. Weber MM, Spottl G, Gossl C, Engelhardt D. Characterization of human insulin-like growth factor-binding proteins by two-dimensional polyacrylamide gel electrophoresis and Western ligand blot analysis. J Clin Endocrinol Metab. 1999;84:1679-1684.
34. Beattie J, Phillips K, Shand JH, Szymanowska M, Flint DJ, Allan GJ. Molecular interactions in the insulin-like growth factor (IGF) axis: A surface plasmon resonance (SPR) based biosensor study. Mol Cell Biochem. 2008;307:221-236.
35. JanssonM,Andersson G, UhlenM,Nilsson B, Kordel J. The insulinlike growth factor (IGF)binding protein 1 binding epitope on IGF-I probed by heteronuclear NMR spectroscopy and mutational analysis. J Biol Chem. 1998;273:24701-24707.
36. Sitar T, Popowicz GM, Siwanowicz I, Huber R, Holak TA. Structural basis for the inhibition of insulin-like growth factors by insulinlike growth factor-binding proteins. Proc Natl Acad Sci USA. 2006; 103:13028-13033.
37. Siwanowicz I, Popowicz GM, Wisniewska M, et al. Structural basis for the regulation of insulin-like growth factors by IGF binding proteins. Structure. 2005;13:155-167.
38. Jansson M, Hallen D, Koho H, et al. Characterization of ligand binding of a soluble human insulin-like growth factor I receptor variant suggests a ligand-induced conformational change. J Biol Chem. 1997;272:8189-8197.
39. Jansson M, Uhlen M, Nilsson B. Structural changes in insulin-like growth factor (IGF) I mutant proteins affecting binding kinetic rates to IGF binding protein 1 and IGF-I receptor. Biochemistry. 1997; 36:4108-4117.
40. Bach LA, Hsieh S, Sakano K, Fujiwara H, Perdue JF, Rechler MM. Binding of mutants of human insulin-like growth factor II to insulinlike growth factor binding proteins 1-6. J Biol Chem. 1993;268: 9246-9254.
41. Carrick FE, Forbes BE, Wallace JC. BIAcore analysis of bovine insulin-like growth factor (IGF)-binding protein-2 identifies major IGF binding site determinants in both the amino-and carboxylterminal domains. J Biol Chem. 2001;276:27120-27128.
42. Dubaquie Y, Mortensen DL, Intintoli A, et al. Binding protein-3-selective insulin-like growth factor I variants: Engineering, biodistributions, and clearance. Endocrinology. 2001;142:165-173.
43. Resnicoff M, Sell C, Ambrose D, Baserga R, Rubin R. Ethanol inhibits the autophosphorylation of the insulin-like growth factor 1 (IGF-1) receptor and IGF-1-mediated proliferation of 3T3 cells. J Biol Chem. 1993;268:21777-21782.
44. Rubini M, Hongo A, D'Ambrosio C, Baserga R. The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: Role of receptor number. Exp Cell Res. 1997;230:284-292.
45. Pietrzkowski Z, Sell C, Lammers R, Ullrich A, Baserga R. Roles of insulinlike growth factor 1 (IGF-1) and the IGF-1 receptor in epidermal growth factor-stimulated growth of 3T3 cells. Mol Cell Biol. 1992;12:3883-3889.
46. Vasilcanu R, Vasilcanu D, Rosengren L, et al. Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: Potential mechanistic involvement of Mdm2 and α-arrestin1. Oncogene. 2008;27:1629-1638.
47. Koistinen R, Itkonen O, Selenius P, Seppala M. Insulin-like growth factor-binding protein-1 inhibits binding of IGF-I on fetal skin fibroblasts but stimulates theirDNAsynthesis. Biochem Biophys Res Commun. 1990;173:408-415.
48. Clemmons DR, Gardner LI.Afactor contained in plasma is required for IGF binding protein-1 to potentiate the effect of IGF-I on smooth muscle cell DNA synthesis. J Cell Physiol. 1990;145:129-135.
49. Westwood M, Gibson JM, Davies AJ, Young RJ, White A. The phosphorylation pattern of insulin-like growth factor-binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy. J Clin Endocrinol Metab. 1994;79: 1735-1741.
50. Frost RA, Tseng L. Insulin-like growth factor-binding protein-1 is phosphorylated by cultured human endometrial stromal cells and multiple protein kinases in vitro. J Biol Chem. 1991;266:18082-18088.
51. Ros S, Garcia-Rocha M, Dominguez J, Ferrer JC, Guinovart JJ. Control of liver glycogen synthase activity and intracellular distribution by phosphorylation. J Biol Chem. 2009;284:6370-6378.
52. Luz S, Kongsuphol P, Mendes AI, et al. Contribution of casein kinase 2 and spleen tyrosine kinase to CFTR trafficking and protein kinase A-induced activity. Mol Cell Biol. 2011;31:4392-4404.